Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H N Langstein

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Seminars in Surgical Oncology|July 14, 1999
Reconstructive approaches in soft tissue sarcomaH N Langstein, G L Robb
Hematology/Oncology Clinics of North America|February 1, 1991
Mechanisms of cancer cachexiaH N Langstein, J A Norton
Plastic and Reconstructive Surgery|February 1, 1997
How to use a gel template for an exact facial flap transferH N Langstein, B M Zide
Clinics in Plastic Surgery|June 13, 2001
Coverage of skull base defectsH N Langstein, D W Chang, G L Robb
The Journal of Experimental Medicine|September 1, 1989
Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicityD L Fraker, H N Langstein, J A Norton
AJNR. American Journal of Neuroradiology|February 13, 2001
MR imaging of the muscular component of myocutaneous flaps in the head and neckJ Chong, L L Chan, H N Langstein, et al.
The Annals of Otology, Rhinology, and Laryngology|April 20, 2001
Malignant melanoma arising within a burn scar case report and review of the literatureP M Spring, J N Myers, A K El-Naggar, et al.
Cancer Research|May 1, 1991
The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexiaH N Langstein, G M Doherty, D L Fraker, et al.
Cancer Research|July 1, 1990
Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factorB C Sheppard, D Venzon, D L Fraker, et al.
Surgical Oncology|February 1, 1992
Tumour necrosis factor mediates the survival benefit of interleukin 2 in a murine pulmonary metastases modelD L Fraker, A K Thom, G M Doherty, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Seminars in Surgical Oncology|July 14, 1999
Reconstructive approaches in soft tissue sarcomaH N Langstein, G L Robb
Hematology/Oncology Clinics of North America|February 1, 1991
Mechanisms of cancer cachexiaH N Langstein, J A Norton
Plastic and Reconstructive Surgery|February 1, 1997
How to use a gel template for an exact facial flap transferH N Langstein, B M Zide
Clinics in Plastic Surgery|June 13, 2001
Coverage of skull base defectsH N Langstein, D W Chang, G L Robb
The Journal of Experimental Medicine|September 1, 1989
Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicityD L Fraker, H N Langstein, J A Norton
AJNR. American Journal of Neuroradiology|February 13, 2001
MR imaging of the muscular component of myocutaneous flaps in the head and neckJ Chong, L L Chan, H N Langstein, et al.
The Annals of Otology, Rhinology, and Laryngology|April 20, 2001
Malignant melanoma arising within a burn scar case report and review of the literatureP M Spring, J N Myers, A K El-Naggar, et al.
Cancer Research|May 1, 1991
The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexiaH N Langstein, G M Doherty, D L Fraker, et al.
Cancer Research|July 1, 1990
Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factorB C Sheppard, D Venzon, D L Fraker, et al.
Surgical Oncology|February 1, 1992
Tumour necrosis factor mediates the survival benefit of interleukin 2 in a murine pulmonary metastases modelD L Fraker, A K Thom, G M Doherty, et al.
Pageof 3